Spots Global Cancer Trial Database for fluorine f 18 sodium fluoride
Every month we try and update this database with for fluorine f 18 sodium fluoride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases | NCT00936975 | Hormone-Resista... Metastatic Mali... Recurrent Prost... Stage IV Prosta... | Fluorine F 18 S... | 18 Years - | National Cancer Institute (NCI) | |
| NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer | NCT02429804 | Hormone-Resista... Metastatic Mali... Metastatic Pros... | Contrast-enhanc... Fludeoxyglucose... Fluorine F 18 S... Magnetic Resona... Positron Emissi... | 19 Years - | Stanford University | |
| NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer | NCT02429804 | Hormone-Resista... Metastatic Mali... Metastatic Pros... | Contrast-enhanc... Fludeoxyglucose... Fluorine F 18 S... Magnetic Resona... Positron Emissi... | 19 Years - | Stanford University | |
| NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer | NCT02429804 | Hormone-Resista... Metastatic Mali... Metastatic Pros... | Contrast-enhanc... Fludeoxyglucose... Fluorine F 18 S... Magnetic Resona... Positron Emissi... | 19 Years - | Stanford University | |
| NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis | NCT01816048 | Prostatic Neopl... Prostate Cancer | TAK-700 Fluorine F 18 S... Positron Emissi... Computed Tomogr... | 18 Years - | University of Wisconsin, Madison | |
| Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer | NCT01967862 | Recurrent Prost... | computed tomogr... bone scan 3-Tesla magneti... diffusion-weigh... fluorine F 18 s... computed tomogr... positron emissi... laboratory biom... | 18 Years - | City of Hope Medical Center | |
| Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer | NCT01967862 | Recurrent Prost... | computed tomogr... bone scan 3-Tesla magneti... diffusion-weigh... fluorine F 18 s... computed tomogr... positron emissi... laboratory biom... | 18 Years - | City of Hope Medical Center | |
| Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases | NCT00936975 | Hormone-Resista... Metastatic Mali... Recurrent Prost... Stage IV Prosta... | Fluorine F 18 S... | 18 Years - | National Cancer Institute (NCI) | |
| NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer | NCT02429804 | Hormone-Resista... Metastatic Mali... Metastatic Pros... | Contrast-enhanc... Fludeoxyglucose... Fluorine F 18 S... Magnetic Resona... Positron Emissi... | 19 Years - | Stanford University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
